DOD Enhances the Business by Acquiring PCCA to Surge above a Crumbling Market
DOD acquired PCCA on December 19, 2018, and the positive sentiment has buoyed the share to surge in the opposite way of the current market situation.
20 ธ.ค. 2561

At 15:05, the price of DOD Biotech Public Company Limited (DOD)’s shares is ฿13.90/share, gains ฿0.20 or 1.46% with ฿39.7 million in value. The highest of the day is ฿14.20/share and the lowest is ฿13.70/share.
The shares have been hiking in an opposite way of Thai stock market since the announcement of an investment in PCCA Laboratory Co., Ltd. (PCCA) to expand its supplementary business and advance in a complete range of Health &amp; Beauty business.
 
Today, Ms. Supamas Isarabhakdi, DOD’s Chairman of Executive Committee, has made a conference through the live broadcast with “Kaohoon” to give further details regarding the takeover of PCCA, a cosmetic and skin care OEM manufacturer, with an investment value of ฿297 million. Ms. Supamas asserts that the takeover is diversification as DOD’s business is solely in a supplementary field, while PCCA has a complete range of cosmetic and skin care business.
Moreover, this investment in PCCA will add more value to DOD, while enhancing the business with PCCA’s strong customer base that will be able to strengthen DOD and further its growth even more. Ms. Supamas has set a gross profit margin at 40% after the acquisition.
PCCA is a leading of manufacturer and OEM supplier of personal care products, cosmetic products and cosmeceutical products under client’s private label products for the domestic market.
 